StockData
ProKidney Corp. logo

ProKidney Corp. (PROK) stock

PROKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.10+0.06 (+5.77%)

Close on Nov 17, 2026Market cap $332.56MP/E –Yield –

ProKidney operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

ProKidney's operating cash flow for the twelve months ending Jun 30, 2026 was -$141.17M. For fiscal 2025 it was -$120.12M. The highest annual figure on record is -$25.18M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$120.12M–
FY2024Dec 31, 2024-$126.35M–
FY2023Dec 31, 2023-$90.07M–
FY2022Dec 31, 2022-$77.09M–
FY2021Dec 31, 2021-$50.30M–
FY2020Dec 31, 2020-$25.18M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$40.37M–
Q1 FY2026Mar 31, 2026-$41.68M–
Q4 FY2025Dec 31, 2025-$32.51M–
Q3 FY2025Sep 30, 2025-$26.60M–
Q2 FY2025Jun 30, 2025-$31.42M–
Q1 FY2025Mar 31, 2025-$29.59M–
Q4 FY2024Dec 31, 2024-$24.17M–
Q3 FY2024Sep 30, 2024-$29.24M–
Q2 FY2024Jun 30, 2024-$38.29M–
Q1 FY2024Mar 31, 2024-$34.65M–
Q4 FY2023Dec 31, 2023-$25.38M–
Q3 FY2023Sep 30, 2023-$23.78M–
Q2 FY2023Jun 30, 2023-$14.92M–
Q1 FY2023Mar 31, 2023-$25.99M–
Q4 FY2022Dec 31, 2022-$15.76M–
Q3 FY2022Sep 30, 2022-$22.84M–
Q2 FY2022Jun 30, 2022-$23.03M–
Q1 FY2022Mar 31, 2022-$15.46M–
Q4 FY2021Dec 31, 2021-$12.99M–

More ProKidney figures

See a number that looks wrong?